| |
N (%)
|
|---|
|
Age (years)
| |
|
· Median (range)
|
68 (45–87)
|
|
Gender
| |
|
· Female
|
34 (37.0%)
|
|
· Male
|
58 (63.0%)
|
|
Primary tumor location
| |
|
· Right colon
|
27 (29.3%)
|
|
· Transverse colon
|
5 (5.4%)
|
|
· Left colon
|
9 (9.8%)
|
|
· Sigmoid colon
|
18 (19.6%)
|
|
· Recto sigmoid colon
|
14 (15.2%)
|
|
· Rectum
|
19 (20.7%)
|
|
Histology
| |
|
· Conventional adenocarcinoma
|
79 (85.9%)
|
|
· Mucinous or colloid adenocarcinoma
|
12 (13.0%)
|
|
· Signet ring cell adenocarcinoma
|
1 (1.1%)
|
|
Tumor differentiation
| |
|
· Well differentiated
|
22 (23.9%)
|
|
· Moderately differentiated
|
46 (50.0%)
|
|
· Poorly differentiated
|
12 (13.0%)
|
|
TNM stage
| |
|
· I
|
8 (8.7%)
|
|
· II
|
22 (23.9%)
|
|
· III
|
24 (26.1%)
|
|
· IV
|
37 (40.2%)
|
|
· Unknown
|
1 (1.1%)
|
|
Baseline CEA (ng/mL)
| |
|
· High
|
33 (35.9%)
|
|
· Normal
|
59 (64.1%)
|
|
· Median (range)
|
3 (0–13.318)
|
- TNM: Tumor, Node and Metastases; CEA: carcinoembryonic antigen.
